{"title":"射频场诱导的放射致敏与代谢活性降低有关","authors":"Angela Chinhengo, A. Serafin, J. Akudugu","doi":"10.1615/plasmamed.2020032850","DOIUrl":null,"url":null,"abstract":"Although radiofrequency fields (RFFs) have been found to exhibit both radiosensitizing (enhancement of radiation) and radioprotective (mitigation of radiation) effects, mechanisms underlying these phenomena have not been clearly elucidated. Here, we use four human cell lines, namely, MeWo and Be11 (melanomas), DU145 (prostate carcinoma), and L132 (normal lung fibroblasts), to assess the role of RFF modulation of cellular metabolic activity in altering radiosensitivity. We measure radiosensitivity and metabolic activity using colony-forming and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, respectively. Cell lines that are more radiosensitized by RFF exposure show larger reductions in metabolic activity, relative to radiation treatment alone, regardless of whether RFF exposure occurs before or after X-ray irradiation. The finding that surviving cells maintain elevated metabolic activity when treated with a combination of RFFs and X-rays suggests that changes in metabolic activity may be triggered by RFFs to support processes such as DNA repair and alteration of long-term cell survival. Modulation of cellular metabolic activity by RFFs may have important ramifications for moderating ionizing radiation–induced effects. This must be carefully considered if RFFs are to be applied as adjuvants in radiotherapy.","PeriodicalId":53607,"journal":{"name":"Plasma Medicine","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1615/plasmamed.2020032850","citationCount":"0","resultStr":"{\"title\":\"Radiofrequency Field-Induced Radiosensitization Is Related to Reductions in Metabolic Activity\",\"authors\":\"Angela Chinhengo, A. Serafin, J. Akudugu\",\"doi\":\"10.1615/plasmamed.2020032850\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although radiofrequency fields (RFFs) have been found to exhibit both radiosensitizing (enhancement of radiation) and radioprotective (mitigation of radiation) effects, mechanisms underlying these phenomena have not been clearly elucidated. Here, we use four human cell lines, namely, MeWo and Be11 (melanomas), DU145 (prostate carcinoma), and L132 (normal lung fibroblasts), to assess the role of RFF modulation of cellular metabolic activity in altering radiosensitivity. We measure radiosensitivity and metabolic activity using colony-forming and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, respectively. Cell lines that are more radiosensitized by RFF exposure show larger reductions in metabolic activity, relative to radiation treatment alone, regardless of whether RFF exposure occurs before or after X-ray irradiation. The finding that surviving cells maintain elevated metabolic activity when treated with a combination of RFFs and X-rays suggests that changes in metabolic activity may be triggered by RFFs to support processes such as DNA repair and alteration of long-term cell survival. Modulation of cellular metabolic activity by RFFs may have important ramifications for moderating ionizing radiation–induced effects. This must be carefully considered if RFFs are to be applied as adjuvants in radiotherapy.\",\"PeriodicalId\":53607,\"journal\":{\"name\":\"Plasma Medicine\",\"volume\":\"16 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1615/plasmamed.2020032850\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Plasma Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1615/plasmamed.2020032850\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Physics and Astronomy\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasma Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1615/plasmamed.2020032850","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Physics and Astronomy","Score":null,"Total":0}
Radiofrequency Field-Induced Radiosensitization Is Related to Reductions in Metabolic Activity
Although radiofrequency fields (RFFs) have been found to exhibit both radiosensitizing (enhancement of radiation) and radioprotective (mitigation of radiation) effects, mechanisms underlying these phenomena have not been clearly elucidated. Here, we use four human cell lines, namely, MeWo and Be11 (melanomas), DU145 (prostate carcinoma), and L132 (normal lung fibroblasts), to assess the role of RFF modulation of cellular metabolic activity in altering radiosensitivity. We measure radiosensitivity and metabolic activity using colony-forming and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, respectively. Cell lines that are more radiosensitized by RFF exposure show larger reductions in metabolic activity, relative to radiation treatment alone, regardless of whether RFF exposure occurs before or after X-ray irradiation. The finding that surviving cells maintain elevated metabolic activity when treated with a combination of RFFs and X-rays suggests that changes in metabolic activity may be triggered by RFFs to support processes such as DNA repair and alteration of long-term cell survival. Modulation of cellular metabolic activity by RFFs may have important ramifications for moderating ionizing radiation–induced effects. This must be carefully considered if RFFs are to be applied as adjuvants in radiotherapy.
Plasma MedicinePhysics and Astronomy-Physics and Astronomy (all)
CiteScore
1.40
自引率
0.00%
发文量
14
期刊介绍:
Technology has always played an important role in medicine and there are many journals today devoted to medical applications of ionizing radiation, lasers, ultrasound, magnetic resonance and others. Plasma technology is a relative newcomer to the field of medicine. Experimental work conducted at several major universities, research centers and companies around the world over the recent decade demonstrates that plasma can be used in variety of medical applications. It is already widely used surgeries and endoscopic procedures. It has been shown to control properties of cellular and tissue matrices, including biocompatibility of various substrates. Non-thermal plasma has been demonstrated to deactivate dangerous pathogens and to stop bleeding without damaging healthy tissue. It can be used to promote wound healing and to treat cancer. Understanding of various mechanisms by which plasma can interact with living systems, including effects of reactive oxygen species, reactive nitrogen species and charges, has begun to emerge recently. The aim of the Plasma Medicine journal will be to provide a forum where the above topics as well as topics closely related to them can be presented and discussed. Existing journals on plasma science and technology are aimed for audiences with primarily engineering and science background. The field of Plasma Medicine, on the other hand, is highly interdisciplinary. Some of prospective readers and contributors of the Plasma Medicine journal are expected to have background in medicine and biology. Others might be more familiar with plasma science. The goal of the proposed Plasma Medicine journal is to bridge the gap between audiences with such different backgrounds, without sacrificing the quality of the papers be their emphasis on medicine, biology or plasma science and technology.